Cancer incidence in korean vietnam veterans during 1992-2003: The Korean veterans health study

Journal of Preventive Medicine and Public Health

Volumn 46, Issue 6, 2013, Pages 309-318

  Yi, Sang Wook ^a  

^a Catholic Kwandong University   (South Korea)

Author keywords

Cohort studies; Incidence; Korea; Neoplasms; Veterans; Vietnam War

Indexed keywords

HERBICIDE;

ADULT; AGED; ARMY; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; KIDNEY CANCER; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; PROSTATE CANCER; STANDARDIZED INCIDENCE RATIO; T CELL LYMPHOMA; VERY ELDERLY; VETERAN;

COHORT STUDIES; INCIDENCE; KOREA; NEOPLASMS; VETERANS; VIETNAM WAR;

ADULT; AGED; AGED, 80 AND OVER; HERBICIDES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; REPUBLIC OF KOREA; VETERANS; VIETNAM CONFLICT;

EID: 84892713075     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2013.46.6.309     Document Type: Article

References (38)

1. Institute of Medicine. Veterans and Agent Orange: update 2010. Washington, DC: National Academy Press; 2011, p. 7-10, 54-59.
2. Stellman JM, Stellman SD, Christian R, Weber T, Tomasallo C. The extent and patterns of usage of Agent Orange and other herbicides in Vietnam. Nature 2003;422(6933):681-687.
3. Young AL, Calcagni JA, Thalken CE, Tremblay JW. The toxicology, environmental fate, and human risk of herbicide Orange and Its associated dioxin. Brooks Air Force Base: USAF Occupational and Environmental Health Laboratory; 1978, p. I21-I25.
4. Institute of Medicine. Veterans and Agent Orange: health effects of herbicides used in Vietnam. Washington, DC: National Academy Press; 1994, p. 84-107.
5. Yi SW, Ohrr HC. Mortality patterns among Korean Vietnam veterans. Korean J Occup Environ Med 2011;23(3):279-286 (Korean).
6. International Agency for Research on Cancer. Agents classified by the IARC monographs. Vol. 1-109 [cited 2013 July 20]. Available from: http://monographs.iarc.fr/ENG/Classification.
7. National Toxicology Program. 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Rep Carcinog 2011;12:396-398.
8. Akhtar FZ, Garabrant DH, Ketchum NS, Michalek JE. Cancer in US Air Force veterans of the Vietnam War. J Occup Environ Med 2004;46(2):123-136.
9. Ketchum NS, Michalek JE, Burton JE. Serum dioxin and cancer in veterans of Operation Ranch Hand. Am J Epidemiol 1999;149(7):630-639.
10. Wilson EJ, Horsley KW, van der Hoek R. Cancer incidence in Australian Vietnam Veterans Study 2005. Canberra: Department of Veterans' Affairs; 2005, p. 79-105.
11. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54(2):78-93.
12. Ohrr H, Yi SW, Hong JS, Yi JJ, Kang HJ, Won JU, et al. An epidemiologic study on the adverse health effects of Agent Orange among Vietnam veterans. Seoul: Yonsei University Health System; 2006, p. 117-118 (Korean).
13. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. Vol. IX. Lyon: International Agency for Research on Cancer; 2008, p. 40-44, 242-243.
14. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998, p. 260-264.
15. Lynge E. Cancer incidence in Danish phenoxy herbicide workers, 1947-1993. Environ Health Perspect 1998;106 Suppl 2:683-688.
16. Mikoczy Z, Rylander L. Mortality and cancer incidence in cohorts of Swedish fishermen and fishermen's wives: updated findings. Chemosphere 2009;74(7):938-943.
17. Boehmer TK, Flanders WD, McGeehin MA, Boyle C, Barrett DH. Postservice mortality in Vietnam veterans: 30-year follow-up. Arch Intern Med 2004;164(17):1908-1916.
18. Wilson EJ, Horsley KW, van der Hoek R. Australian Vietnam Veterans Mortality Study 2005. Canberra: Department of Veterans' Affairs; 2005, p. 69-91.
19. Cypel Y, Kang H. Mortality patterns among women Vietnam-era veterans: results of a retrospective cohort study. Ann Epidemiol 2008;18(3):244-252.
20. Choi YH. Vietnam War. Seoul: Ministry of National Defence, Institute for National Defence and Military History; 2004, p. 168-171 (Korean).
21. Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol 1997;145(12):1061-1075.
22. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p- dioxin. J Natl Cancer Inst 1999;91(9):779-786.
23. Boffetta P, Mundt KA, Adami HO, Cole P, Mandel JS. TCDD and cancer: a critical review of epidemiologic studies. Crit Rev Toxicol 2011;41(7):622-636.
24. Fritz WA, Lin TM, Cardiff RD, Peterson RE. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis 2007;28(2):497-505.
25. Gupta A, Ketchum N, Roehrborn CG, Schecter A, Aragaki CC, Michalek JE. Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Environ Health Perspect 2006;114(11):1649-1654.
26. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer 2008;113(9):2464-2470.
27. Li CY, Sung FC. A review of the healthy worker effect in occupational epidemiology. Occup Med (Lond) 1999;49(4):225-229.
28. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20(4):417-435.
29. Wolfe WH, Michalek JE, Miner JC, Rahe A, Silva J, Thomas WF, et al. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. I. Physical health. JAMA 1990;264(14):1824-1831.
30. Nagel G, Linseisen J, Boshuizen HC, Pera G, Del Giudice G, Westert GP, et al. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Epidemiol 2007;36(1):66-76.
31. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997;89(17):1277-1284.
32. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009;38(4):978-988.
33. Mao Y, Hu J, Ugnat AM, Semenciw R, Fincham S; Canadian Cancer Registries Epidemiology Research Group. Socioeconomic status and lung cancer risk in Canada. Int J Epidemiol 2001;30(4):809-817.
34. Joshi S, Song YM, Kim TH, Cho SI. Socio-economic status and the risk of liver cancer mortality: a prospective study in Korean men. Public Health 2008;122(11):1144-1151.
35. Groome PA, Schulze KM, Keller S, Mackillop WJ, O'Sullivan B, Irish JC, et al. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) 2006;18(4):283-292.
36. Aarts MJ, Lemmens VE, Louwman MW, Kunst AE, Coebergh JW. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer 2010;46(15):2681- 2695.
37. Pesatori AC, Consonni D, Rubagotti M, Grillo P, Bertazzi PA. Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up. Environ Health 2009;8:39.
38. Jung KW, Won YJ, Park S, Kong HJ, Sung J, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci 2009;24(6):995-1003.